nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A mouse model of the Δ133p53 isoform: roles in cancer progression and inflammation
|
Kazantseva, Marina |
|
2018 |
29 |
11-12 |
p. 831-842 |
artikel |
2 |
B cells and antibody production in melanoma
|
Da Gama Duarte, Jessica |
|
2018 |
29 |
11-12 |
p. 790-805 |
artikel |
3 |
Correction to: The role of proteomics in the age of immunotherapies
|
Hayes, Sarah A. |
|
2018 |
29 |
11-12 |
p. 770 |
artikel |
4 |
Identifying neoantigens for use in immunotherapy
|
Hutchison, Sharon |
|
2018 |
29 |
11-12 |
p. 714-730 |
artikel |
5 |
Immune cell profiling in the age of immune checkpoint inhibitors: implications for biomarker discovery and understanding of resistance mechanisms
|
Lim, Su Yin |
|
2018 |
29 |
11-12 |
p. 866-878 |
artikel |
6 |
Interaction of PVR/PVRL2 with TIGIT/DNAM-1 as a novel immune checkpoint axis and therapeutic target in cancer
|
Stamm, Hauke |
|
2018 |
29 |
11-12 |
p. 694-702 |
artikel |
7 |
Introduction to Mammalian Genome special issue: inflammation and immunity in cancer
|
Behren, Andreas |
|
2018 |
29 |
11-12 |
p. 691-693 |
artikel |
8 |
Lessons learnt from the Tasmanian devil facial tumour regarding immune function in cancer
|
Peel, Emma |
|
2018 |
29 |
11-12 |
p. 731-738 |
artikel |
9 |
Manipulating the tumor microenvironment by adoptive cell transfer of CAR T-cells
|
Gowrishankar, Kavitha |
|
2018 |
29 |
11-12 |
p. 739-756 |
artikel |
10 |
NLRP3 inflammasome in colitis and colitis-associated colorectal cancer
|
Perera, Agampodi Promoda |
|
2018 |
29 |
11-12 |
p. 817-830 |
artikel |
11 |
Perspective: cancer vaccines in the era of immune checkpoint blockade
|
Cebon, Jonathan |
|
2018 |
29 |
11-12 |
p. 703-713 |
artikel |
12 |
Radiation, inflammation and the immune response in cancer
|
McKelvey, Kelly J. |
|
2018 |
29 |
11-12 |
p. 843-865 |
artikel |
13 |
Roles of cytotoxic and helper innate lymphoid cells in cancer
|
Guillerey, Camille |
|
2018 |
29 |
11-12 |
p. 777-789 |
artikel |
14 |
The intertwined fates of inflammation and coagulation in glioma
|
Cho, Angela |
|
2018 |
29 |
11-12 |
p. 806-816 |
artikel |
15 |
The role of proteomics in the age of immunotherapies
|
Hayes, Sarah A. |
|
2018 |
29 |
11-12 |
p. 757-769 |
artikel |
16 |
Thymocyte self-renewal and oncogenic risk in immunodeficient mouse models: relevance for human gene therapy clinical trials targeting haematopoietic stem cell populations?
|
Ginn, Samantha L. |
|
2018 |
29 |
11-12 |
p. 771-776 |
artikel |